Because there is competition. IPIX have safe and effective drugs. 8 human mid stage trials prove that. 20 plus CDAs prove there is major interest. BP needs to refill pipelines to keep shareholders happy.
B-OM will be the leader in an untapped market. You better believe someone will jump ahead the next to gain 500 million plus a year into the billions potentially.